The Business Research Company’s report on the Sterile Compounding Pharmacies Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the sterile compounding pharmacies market further?
Increasing demand for personalized medicine is expected to propel the growth of the sterile compounding pharmacies market going forward. Personalized medicine is a type of medicine that prevents, diagnoses, or treats disease by using information about a person’s genes or proteins. Sterile compounding pharmacies play a significant role in offering personalized medications to patients in a sterile environment to provide customized medication to people based on their needs and avoid the possibility of intolerance to certain doses or drug compounds. This improves treatment results and increase patient satisfaction and adherence to therapy. For instance, in 2022, according to the report published by Personalized Medicine Coalition, a US-based company operating in personalized medicine services, personalized medicines have now accounted for at least a quarter of new medication approvals, with the approval of 12 new personalized medicines in 2022 which has increased dramatically. Therefore, the increasing demand for personalized medicine is driving the sterile compounding pharmacies market.
Access Your Free Sample of the Global Sterile Compounding Pharmacies Market Report – Get Insights Now!
Sterile Compounding Pharmacies Market Report 2025, Overview and Growth Sample
What are the key factors influencing the forecasted market size of the sterile compounding pharmacies industry?
The sterile compounding pharmacies market size has grown strongly in recent years. It will grow from $5.34 billion in 2024 to $5.63 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to patient safety concerns, a shift towards personalized medicine, home infusion therapies, clinical trials and investigational drugs, and support for rare diseases
The sterile compounding pharmacies market size is expected to see strong growth in the next few years. It will grow to $7.3 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to a rise in chronic diseases, aging population and healthcare needs, drug shortages and supply chain disruptions, advancements in precision medicine, increased focus on patient-centric care. Major trends in the forecast period include automation and robotics integration, stringent regulatory compliance, personalized medicine and specialized compounds, shift to outsourced compounding services, and technological advances in aseptic techniques.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
Sterile Compounding Pharmacies Market Report 2025, Overview and Growth Customise
Who are the leading competitors in the sterile compounding pharmacies market?
Major companies operating in the sterile compounding pharmacies market include B. Braun SE, PharMerica Corporation, Fagron Group BV, QuVa Pharma Inc., NewCo Pharma GmbH, Medisca, PharMEDium Healthcare Holdings Inc., Central Admixture Pharmacy Services (CAPS), SandsRx LLC, LeeSar Inc., Avella Specialty Pharmacy, Stokes Pharmacy Inc., Imprimis Pharmaceuticals Inc., Wells Pharmacy Network LLC, McGuff Compounding Pharmacy Services Inc., Potter’s House Apothecary Inc., Pharos Innovations LLC, Triangle Compounding Pharmacy Inc., Valor Compounding Pharmacy Inc., Pace Pharmacy, PenCol Specialty Pharmacy LLC, Pavilion Compounding Pharmacy LLC, Olympia Pharmacy, MedisourceRx, Stat RX Pharmacy, Rx3 Compounding Pharmacy, Atlas Pharmaceuticals Co. Ltd., ReNue Rx, Premier Pharmacy Labs Inc., Absolute Pharmacy Inc.
Which emerging trends are set to transform the sterile compounding pharmacies market landscape?
The adoption of robotic automation is a key trend gaining popularity in the sterile compounding pharmacies market. Major companies operating in the sterile compounding pharmacies market are focused on robotic automation to strengthen their position in the market. For instance, in March 2023, Omnicell Inc., a US-based healthcare technology company, introduced IVX Station, a robotic compounding technology for safe and efficient sterile compounding preparations using automation. The IVX Station features an automated compounding process in an ISO Class 5 environment, as well as temperature, humidity, and particle monitoring continually. It was also designed with safety in mind, with advanced vision systems, gravimetric verification, auto-labeling, and automated application of tamper-evident syringe caps. Furthermore, this new technology allows for scalability with a cloud-based formulation library, which is constantly updated to guarantee manufacturers access to the most recent authorized formulations.
How do different geographies compare in terms of market share and growth potential in the sterile compounding pharmacies market?
North America was the dominant region in the sterile compounding pharmacies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sterile compounding pharmacies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
Sterile Compounding Pharmacies Market Report 2025, Overview and Growth
Which major segments of the sterile compounding pharmacies market are experiencing the fastest growth?
The sterile compounding pharmacies market covered in this report is segmented –
1) By Product: Injectables, Nasal, Ocular, Otic
2) By Therapeutic Area: Hormone Replacement Therapy, Pain Management, Dermatology, Oncology, Hematology, Dental, Other Therapeutic Areas
3) By Route Of Administrations: Intravenous, Intramuscular, Subcutaneous
4) By End-Users: Adults, Pediatrics, Geriatrics, Veterinary
Subsegments:
1) By Injectables: Sterile Solutions, Sterile Suspensions, Sterile Powders For Reconstitution
2) By Nasal: Nasal Sprays, Nasal Solutions, Nasal Gels
3) By Ocular: Ophthalmic Solutions, Ophthalmic Suspensions, Ocular Inserts
4) By Otic: Otic Solutions, Otic Suspensions, Otic Gels
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
Sterile Compounding Pharmacies Market Report 2025, Overview and Growth
How is the sterile compounding pharmacies market defined, and what are its core characteristics?
Sterile compounding pharmacies are specialized pharmacies that prepare customized medications in a sterile environment to offer tailored medication to individuals to their specific needs. This can be beneficial to people for several reasons such as patient intolerance to a particular commercial dose or an intolerance to a specific constituent. This compounding allows patients to get drugs with customized doses and formulations that eliminate non-essential and undesirable components.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
